Diaceutics Plc (DXRX) Ord GBP0.002

- Add to watchlist
- Create an alert
- This stock can be held in a




140.00p
142.00p
151.00p
£118.37 million
140.00p
140.00p
107.50p
n/a
2.50p (1.82%) Previous:
2.50p
109,345
n/a
2,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue (£m) | 32.16 | 23.70 |
Profit before tax (£m) | (1.91) | (2.44) |
Adjusted EPS (p): | (2.02) | (2.07) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Diaceutics strengthens partnership with Partner Therapeutics
26 March 2025 11:41
-
Diaceutics wins $5.1m contract with global pharma firm
17 December 2024 13:35
-
Diaceutics awarded £1m in UKRI funding
5 December 2024 13:23
-
PDMR Shareholding/Share Incentive Plan and TVR
2 September 2025 07:00
-
Holding(s) in Company
11 August 2025 10:58
-
Diaceutics at Canaccord Genuity Growth Conference
5 August 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.